ENTERPRISES
BANMEDICA
ESSENTIAL FACT
BANMÉDICA S.A.
Ref.: Informs of the holding of the Ordinary Shareholders’ Meeting.
In accordance with the provisions of Articles 9″ and 10″ of Law No. 18,045 on the Market
of Securities, and in the General Standard N*30 of the Commission for the Market
Financial, duly authorized for this purpose and on behalf of Banmédica S.A. (the
“Company”), I inform as an essential fact that, at the ordinary meeting of shareholders
held on March 17, 2023, the following was approved:
1. The Annual Report, the Consolidated Financial Statements and the Auditors’ Report
External corresponding to the year ended December 31, 2022.
2. Non-distribution of ordinary dividends against profit for the financial year
2022, by virtue of the losses of the financial year 2022, and the absorption of those losses
losses on the Company’s retained earnings.
3. The appointment of PricewaterhouseCoopers as external auditors for the
Fiscal year 2023.
4. The election of Thomas Murray, Fernando Matthews Cádiz, Joseph Colletti and Joel
Velasco as members of the Board of Directors of the Society for the next 3 years.
5. The designation of Feller Rate Risk Classifier and Fitch Ratings Rating
of Risk, as risk classification entities for the year 2023.
6. The designation of the electronic newspaper “El Líbero” for the publications of the
Society.
7. Information on transactions with related parties.
Santiago, March 17, 2023.
MNMA
Fernando Matthews Cadiz
General Manager
Banmédica S.A.
Link to file in CMFChile: https://www.cmfchile.cl/sitio/aplic/serdoc/ver_sgd.php?s567=b7a0cbba33f3b32c0fdb8527f9f5ded2VFdwQmVVMTZRWHBOUkVWNFRrUlpkMDFuUFQwPQ==&secuencia=-1&t=1682376108
